1. Home
  2. AMWL vs MCRB Comparison

AMWL vs MCRB Comparison

Compare AMWL & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$7.69

Market Cap

91.2M

Sector

Technology

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$7.79

Market Cap

85.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
MCRB
Founded
2006
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.2M
85.7M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
AMWL
MCRB
Price
$7.69
$7.79
Analyst Decision
Hold
Buy
Analyst Count
6
2
Target Price
$7.40
$14.00
AVG Volume (30 Days)
60.6K
50.9K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
57.06
N/A
EPS
N/A
N/A
Revenue
N/A
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$6.56
52 Week High
$9.15
$29.98

Technical Indicators

Market Signals
Indicator
AMWL
MCRB
Relative Strength Index (RSI) 72.92 43.53
Support Level $6.84 $6.56
Resistance Level N/A $9.53
Average True Range (ATR) 0.44 0.64
MACD 0.12 0.03
Stochastic Oscillator 98.18 48.04

Price Performance

Historical Comparison
AMWL
MCRB

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: